Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Clinical trial NCT05534620 · COMPLETED

Trial details

NCT number: NCT05534620
Sponsor: medac GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia (AML)Myelodysplastic Syndrome (MDS)Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Start date: 2024-02-01
Primary completion: 2025-05-14
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.